AI in Healthcare & Science · AI Medical Diagnosis

What Happens When AI Diagnostic Tools Make a Mistake?

When an AI diagnostic tool errs, responsibility generally still rests with the supervising clinician and health system rather than the software itself, and errors can trigger internal review, regulatory reporting, and in some cases legal liability processes similar to other medical errors.

Medical disclaimer

This page is for general educational purposes only and is not medical advice. It does not replace a consultation with a licensed physician, pharmacist, or other qualified health provider. Always talk to your own care team before starting, stopping, or changing any medication or supplement.

Key takeaways

Because AI diagnostic tools are generally designed as clinician-support aids, the treating physician typically retains ultimate responsibility for a final diagnostic decision.
Manufacturers of AI medical devices may have reporting obligations to regulators like the FDA when significant errors or safety issues are identified.
Health systems often have internal error-review and quality-improvement processes that apply to AI-related mistakes much as they do to other clinical errors.
Legal liability in cases involving AI errors is a developing and complex area of law that can involve the clinician, the health system, and potentially the tool's manufacturer.
Ongoing monitoring of deployed AI tools is considered an important safeguard precisely because errors and performance drift can occur after initial approval.

Errors Don’t Erase Human Accountability

When an AI diagnostic tool contributes to an incorrect result, the fact that AI was involved doesn’t remove the layers of human oversight and accountability that already exist in medicine. Because these tools are generally designed and regulated as aids to support a clinician’s judgment rather than autonomous decision-makers, the treating physician who reviewed and acted on the AI’s output typically retains ultimate responsibility for the diagnostic decision that was actually made. This is a deliberate feature of how these tools are built into clinical workflows, not an incidental detail.

That said, an AI-related error can also trigger processes beyond the individual clinician. Health systems generally have quality-improvement and error-review procedures that apply to clinical mistakes broadly, and these can extend to cases where an AI tool’s output played a role. Depending on the nature and severity of the issue, manufacturers may also face reporting obligations to regulators.

The Regulatory and Institutional Response

In the United States, AI-based diagnostic software that has been cleared by the FDA as a medical device is generally subject to post-market surveillance requirements, meaning manufacturers can have obligations to report certain malfunctions, adverse events, or safety signals identified after a product is in use. This kind of post-market oversight exists precisely because a tool’s real-world performance, across diverse patients and settings, isn’t guaranteed to exactly replicate the performance seen during pre-market testing — a documented mistake or pattern of underperformance can prompt a regulatory review, labeling changes, or in serious cases, market withdrawal.

At the institutional level, hospitals and health systems that use AI diagnostic tools often build in their own monitoring and review practices, treating AI-related errors similarly to how they’d handle other kinds of clinical mistakes or near-misses — through internal case review, root-cause analysis, and quality-improvement follow-up aimed at understanding what went wrong and preventing recurrence.

Legal Liability Remains a Developing Area

Determining legal liability when an AI tool contributes to patient harm is genuinely complicated, and the law in this space continues to develop. Depending on the specifics of a case — how the tool was marketed, how it was used, what warnings or limitations were disclosed, and applicable state or national law — responsibility could potentially touch the treating clinician, the healthcare institution, or the tool’s manufacturer. There isn’t yet a single, settled framework that cleanly answers every scenario, which is part of why this remains an active area of legal and policy discussion as AI’s role in medicine grows.

Bottom Line

When an AI diagnostic tool makes a mistake, existing structures of clinical accountability, institutional error review, and regulatory oversight generally still apply, with the supervising clinician typically retaining primary responsibility — though legal liability involving AI tools specifically remains a complex, evolving area.

Go deeper

Important caveats

Legal and regulatory frameworks for AI-related medical errors are still evolving and vary by jurisdiction.
This is general information, not legal or medical advice about any specific incident.

Frequently asked questions

Who is legally responsible if an AI tool contributes to a misdiagnosis?

This is a complex and evolving area of law. Responsibility can potentially involve the treating clinician, the healthcare institution, and the AI tool's manufacturer, depending on the circumstances, how the tool was used, and applicable regulations, and outcomes can vary by jurisdiction. It is not a settled, one-size-fits-all answer.

Do manufacturers have to report problems with AI medical devices?

In the United States, manufacturers of medical devices, including many AI-based diagnostic tools cleared by the FDA, are generally subject to post-market safety reporting requirements, which can include reporting certain adverse events or malfunctions to the agency.

Can an AI diagnostic error be caught and corrected before it affects patient care?

This is part of why these tools are typically designed to support rather than replace a clinician's judgment — a supervising physician reviewing the AI's output has the opportunity to catch and correct an error before it translates into a clinical decision, which is a key safeguard built into how these tools are meant to be used.

Sources

[1]Artificial Intelligence and Machine Learning in Software as a Medical Device — U.S. Food and Drug Administration
[2]Health and Human Services — U.S. Department of Health and Human Services

Written by Editorial Team

Last updated July 25, 2026

Get one well-sourced answer a week

No spam. Unsubscribe anytime.